It's almost time for the OutcomeRX team (Joe Morse, Kirby Eng, Brooks Wildasin, and Greg Arms ) to head to Phoenix for the 2023 SIIA National Convention! Throughout the past year, one of the most relevant topics in the space has been cell and gene therapies (CGTs) and their impact on claim costs. OutcomeRx has been working diligently on Patient Access to Costly and Curative Therapies (PACCT), offering the protection needed for financial stability while providing life-altering therapies to plan members. Before deciding to exclude CGTs, discover how we're simplifying access and addressing the cost challenge. Let's connect at the convention and explore the future of self-insurance together! #SIIA2023 #SelfInsurance #CGTTherapies #Innovation
Pharmaceutical Executive
1yGood luck Joe and team!